**Core Concept**
The golden hour in thrombolytic therapy for cerebral stroke refers to the narrow time window during which intravenous administration of thrombolytic agents like alteplase can effectively restore blood flow to the brain and improve patient outcomes. This concept is based on the pathophysiology of ischemic stroke, where early recanalization of occluded cerebral vessels can minimize tissue damage and improve functional recovery.

**Why the Correct Answer is Right**
The correct answer is within 4.5 hours of symptom onset. This time frame is critical because the efficacy of thrombolytic therapy decreases significantly after 4.5 hours, and the risk of intracranial hemorrhage increases. The mechanism behind this is the gradual progression of ischemic damage to the brain tissue, which becomes irreversible beyond a certain point. The tissue plasminogen activator (tPA) works by activating plasminogen to plasmin, which then degrades fibrin clots. However, the effectiveness of tPA is time-dependent, and its administration beyond 4.5 hours is not recommended due to the increased risk of bleeding complications.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is too broad, as the time window for thrombolytic therapy can vary depending on the individual patient's condition and the specific type of stroke.
* **Option B:** This option is incorrect because it is too narrow, as the optimal time window for thrombolytic therapy is generally considered to be within 4.5 hours of symptom onset, rather than a specific time point like 3 hours.
* **Option D:** This option is incorrect because it is not supported by clinical evidence, as the American Heart Association and other guidelines do not recommend a specific time window beyond 4.5 hours.

**Clinical Pearl / High-Yield Fact**
It's essential to note that the patient's eligibility for thrombolytic therapy is determined by a combination of factors, including the time from symptom onset, the severity of the stroke, and the presence of contraindications like recent surgery or bleeding disorders. A thorough evaluation and risk-benefit assessment are necessary before administering tPA.

**Correct Answer:** C. 4.5 hours